Theranostic Bionanomaterials

<p>1. Biodistribution, excretion, and toxicity of inorganic nanoparticles<br>2. Biodistribution, excretion, and toxicity of nanoparticles<br>3. Nanoparticle interaction with immune cells for nanoparticle mediated (anti-cancer) immunotherapy<br>4. Clinical translation of nanomaterials<br>5. Synthetic receptors with bioaffinity for biomedical applications<br>6. Calcium phosphate nanoparticle-based systems for therapeutic delivery<br>7. Graphene and graphene oxide for tissue engineering and regeneration<br>8. Nanomaterials design and tests for neural tissue engineering<br>9. Nanomaterials for wound healing: scope and advancement<br>10. Advanced nanovaccines for immunotherapy applications: from concept to animal tests<br>11. Two-dimensional nanomaterials in cancer theranostics<br>12. Polymeric micelles for tumor theranostics<br>13. Theranostic biomaterials for the regulation of the blood-brain barrier<br>14. Upconversion nanomaterials for near-infrared light-medicated theranostics<br>15. Biofunctional magnetic nanomaterials for diagnosis, therapy and theranostic applications<br>16. AIEgen-based fluorescent nanoparticles for long-term cell tracing<br>17. Multimodal carbon dots as biosensors<br>18. Bionanomaterials as imaging contrast agents<br>19. Nucleotide aptamers as theranostic biomaterials</p> <p>20. Electronic structures of alkaline rare earth fluoride-based upconversion nanomaterials<br>21. Lanthanide-based magnetic resonance imaging metal-responsive agent overview</p>